BSE: GLAND - Gland Pharma Limited

Rentabilität für sechs Monate: 0%
Sektor: Healthcare

Aktionsplan Gland Pharma Limited


Über das Unternehmen

Gland Pharma Limited, a generic injectable-focused company, engages in the development, manufacture, sale, and distribution of pharmaceuticals. The company's primary molecules include heparin sodium, enoxaparin sodium, rocuronium bromide, and daptomycin injections, as well as others.

weitere details
It offers its products for various therapeutic categories, such as anti-infectives, anesthetics, anti-coagulants and their antidotes, anti-malarial, cardiology, gastro-intestinal, hormones and related drugs, fertility supplements, Gnrh agonists and antagonists, as well as anti-neoplastic, gynecological, neurological and central nervous system, respiratory, blood related, ophthalmological and otological, pain/analgesics, vitamins/minerals/nutrients, and others. The company also provides contract development services. It sells its products primarily under a business-to-business model in the United States, Europe, Canada, Australia, India, and internationally. The company was incorporated in 1978 and is based in Hyderabad, India. Gland Pharma Limited is a subsidiary of Fosun Pharma Industrial Pte. Ltd.

ISIN INE068V01023
Валюта inr
Сайт https://www.glandpharma.com
Цена ао 2449.4
Preisänderung pro Tag: 0% (2449.4)
Preisänderung pro Woche: +11.88% (2189.35)
Preisänderung pro Monat: +7.07% (2287.7)
Preisänderung über 3 Monate: 0% (2449.4)
Preisänderung über sechs Monate: 0% (2449.4)
Preisänderung pro Jahr: 0% (2449.4)
Preisänderung über 3 Jahre: 0% (2449.4)
Preisänderung über 5 Jahre: 0% (2449.4)
Preisänderung über 10 Jahre: 0% (2449.4)
Preisänderung seit Jahresbeginn: +7.95% (2268.95)

Unterschätzung

Name Bedeutung Grad
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Gesamt: 2.5

Effizienz

Name Bedeutung Grad
ROA, % 0 0
ROE, % 0 0
Gesamt: 0

Dividenden

Name Bedeutung Grad
Div yield, % 0 0
DSI 0 0
Gesamt: 0

Pflicht

Name Bedeutung Grad
Debt/EBITDA 0 10
Gesamt: 10

Wachstumsimpuls

Name Bedeutung Grad
Rentabilität Revenue, % 0 0
Rentabilität Ebitda, % 0 0
Rentabilität EPS, % 0 0
Gesamt: 0



Adresse: India, Hyderabad, Plot No. 11 & 84. TSIIC Phase: IV - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.glandpharma.com